|
National Drugs Survey shows PSU drug firms lack efficiency and quality in manufacturing
|
|
Peethaambaran Kunnathoor, Chennai
July 31 , 2017
|
|
|
The Union health ministry’s national drug survey has reportedly found
that 69 drug products manufactured and marketed by the public sector
enterprises managed by Central and various state governments failed in
their quality testing.
This highlights the fact that, at a time
when the Union government is encouraging ‘Make-in-India’ initiatives,
all the manufacturing companies in the public sector needs more support
of the government in the areas of technology and skill. Like those in
the private sector, government owned companies need to have a culture of
quality of production. All the public sector enterprises are suffering
from lack of technology support and skilled manpower to compete with big
private firms.
The report of the survey, conducted by the
National Institute of Biologicals, reveals that 30 items of medications
manufactured by the central government owned entity, Indian Drugs and
Pharmaceuticals Ltd (IDPL), at its subsidiary unit in Chennai failed in
the quality testing. All the units of the IDPL are sick and the
government is spending crores of rupees to modernize each unit. But the
net result from all centres is not encouraging.
Similarly, pharma
manufacturing firms owned by various state governments also lack
efficiency. The fact is clear from the drugs survey report. Ten
medicines manufactured by the Uttar Pradesh government enterprise, Uttar
Pradesh Drugs & Pharmaceuticals Ltd, have shown poor results in the
quality test conducted by the central government.
Fifteen
products of the Karnataka Antibiotics & Pharmaceuticals Ltd and
fourteen drugs manufactured by Kerala State Drugs & Pharmaceuticals
Ltd also did not pass the quality test.
This shows that the
public sector drug makers have failed to concentrate on quality issues
and the sector needs government attention in a large scale.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|